Results From a 12-Month Open-Label Phase 1/2 Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease

Authors
Category Primary study
JournalJournal of Inborn Errors of Metabolism and Screening
Year 2018
This article has no abstract
Epistemonikos ID: 6d8fe62ff2a941742fa7cf5024240b388c188aaa
First added on: Feb 09, 2025